Prot #PSMA-617-01: VISION: An International, Prospective, Open-Label, Multicenter, Randomized Phase 3 Study Of 177Lu-PSMA-617 In The Treatment Of Patients With Progressive PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Project: Research project

Project Details

StatusActive
Effective start/end date3/22/193/22/22

Funding

  • PSI CRO AG (Prot #PSMA-617-01)
  • Endocyte, Inc. (Prot #PSMA-617-01)